Compare Microchip Technology Inc. (MCHP) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Microchip Technology Inc. vs Summit Therapeutics Inc — how do they compare? Microchip Technology Inc. trades at $83.27 (market cap $43.72B), while Summit Therapeutics Inc trades at $14.57 (market cap $10.48B). The key difference: Microchip Technology Inc. is far larger — about 4.2× Summit Therapeutics Inc's market cap, and Microchip Technology Inc. pays a 2.26% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| MCHP | SMMT | |
|---|---|---|
Market Cap | $43.72B | $10.48B |
Sector | Technology | Health |
52-Week High | $102.97 | $29.32 |
52-Week Low | $49.02 | $13.05 |
Enterprise Value | $49.01B | $9.90B |
Dividend Yield | 2.26% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Microchip Technology Inc.
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
